How to Build a Synthetic Lethality Screen
The Short Answer
Build two screens, not one: the same library in a mutant background and in an isogenic wild-type background. The synthetic lethal hits are the guides depleted in the mutant but not in the wild type.
Coverage, MOI, and readout follow the standard rules for a dropout screen — the difference is that the interaction is defined by the difference between screens, not by depletion in either alone.
Design
| Element | Requirement |
|---|---|
| Backgrounds | Isogenic pair differing only in the lesion of interest |
| Library | Focused (pathway, druggable set) or genome-wide |
| Replicates | Two to three per background, independent transductions |
| Readout | Dropout over a defined number of doublings |
| Analysis | Interaction score per gene, not raw depletion |
| Validation | Individual reconstruction of the three arms |
The first row is what makes the design interpretable and is the most common failure point: two unrelated lines with the same driver mutation are not an isogenic pair.
Analysis: The Difference Is the Result
A guide that depletes in the mutant background may simply target an essential gene. The synthetic lethal signal is the difference in effect between backgrounds.
Practical points:
- • Normalize each screen to its own baseline before comparing.
- • Model the interaction explicitly (for example, a multiplicative model on guide abundance).
- • Aggregate guides to genes and require consistency across guides.
- • Control the false discovery rate across genes, not guides.
Reporting a list of genes depleted in the mutant background, without the wild-type comparison, is not a synthetic lethality result.
Controls
- • Non-targeting guides in both backgrounds.
- • Known synthetic lethal pairs as positive controls for the analysis pipeline (for example, a PARP–BRCA-type pair if the backgrounds permit).
- • Known essential genes to confirm the screen detects essentiality at all.
- • Guide-level consistency within each hit gene.
Validation: Reconstruct the Arms
For each candidate, rebuild the three-arm experiment individually:
- Lesion A only — viable.
- Target knockout only — viable.
- Both — not viable.
Arm 3 alone is a combination effect. Only the comparison across arms establishes interaction, and this is where most screen papers stop short.
Common Failures
| Symptom | Likely cause |
|---|---|
| Many genes depleted in both backgrounds | General essentiality; interaction score not computed |
| No hits, positive controls fail | Coverage or doubling time insufficient |
| Hits that do not reconstruct | Library quality, or context not isogenic |
| Interaction only at extreme guide depletion | Partial-effect artefact |
Need an isogenic screen pair?
EDITGENE builds matched backgrounds for differential screens, with documented baseline proliferation, verified isogenicity, and downstream three-arm reconstruction of candidate pairs.
Tell us the lesion and the library scope. Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Synthetic lethality is defined relative to a specific pair of contexts; results in one background pair are not transferable to another without testing.
Screen hits require three-arm reconstruction; interaction scores depend on the model used and should be reported with it.
Selected references for further reading
- • O'Neil NJ, et al. Synthetic lethality and cancer. Nature Reviews Genetics. 2017;18:613–623.
- • Shen JP, et al. Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. Nature Methods. 2017;14:573–576.
- • Hart T, et al. Evaluation and design of genome-wide CRISPR/SpCas9 knockout screens. G3. 2017;7:2719–2727.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »